Colorectal Cancer Treatment Market Size to Hit USD 26 Billion by 2030
“ Global Colorectal Cancer Treatment Market” the new research report added in Data Bridge Market Research’s reports database. This Research Report spread across 220 No of Tables, And 60 No of Figures summarizing Top companies, with tables and figures. Insulin market report presents the best market and business solutions to Insulin industry in this rapidly revolutionizing market place to thrive in the market. This Insulin market research report is a careful investigation of current scenario of the market and future estimations which spans several market dynamics.
Data Bridge Market Research analyses a growth rate in the colorectal cancer treatment market in the forecast period 2023-2030. The expected CAGR of colorectal cancer treatment market is tend to be around 4% in the mentioned forecast period. The market is valued at USD 19 billion in 2022, and it would grow upto USD 26 billion by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Download PDF Sample Report (Including Graphs, Charts, and List of Figures) @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-colorectal-cancer-treatment-market&Shri
Market Overview:
Colorectal cancer treatment involves a varied number of drugs that are responsible for the treatment of colorectal cancer. Colorectal cancer primarily affects the older adults however it can affect any age groups. Signs and symptoms related with the colorectal cancer are weight loss, weakness, abdominal discomfort, fatigue, pain, persistent change in the bowel habits including diarrhea and constipation, cramps, rectal bleeding, blood in the stools and others.
Drivers
- Increasing Prevalence of Cancer
As per American Cancer Society, men tend to have a 1 in 23 lifetime risk of having colorectal cancer, whereas women have a 1 in 25. Women are at a moderately lower risk than men. Colorectal cancer is the third most frequent cancer in men and the second most common cancer in women. More than 1.8 million new cases were witnessed in 2018. People surviving with localized stage colorectal cancer tend to have a 90% chance of surviving after five years. About 39% of cases are diagnosed at this early stage. The 5-year survival rate is 71% if cancer ranges to neighbouring tissues, organs, or regional lymph nodes. Thus, this factor boost the market growth.
- Rising Healthcare Expenditure And Government Support
With the growing pervasiveness of cancer, the increasing awareness for the disease and the associated treatment is also rising. Government initiatives tend to provide better and more affordable treatments along with favourable reimbursement policies which are anticipated to boost the industry growth. Additionally, growing acceptance of advanced therapies such as Erbitux (cetuximab), Avastin (bevacizumab), and Stivarga (regorafenib) is estimated to drive the market. Amgen and Allergan’s Mvasi was the first biosimilar to Avastin which was approved in U.S. and Europe, therefore marking the entry of biosimilars in the sector of oncology. Numerous other bevacizumab and cetuximab biosimilars are under development and most likely to impact branded sales when launched.
Recent Development
- In 2020, Taiho Pharmaceutical Co., Ltd. launched LONSURF which is an anticancer drug, to treat colorectal cancer patients in China. The company anticipated that Lonsurf would lead to patients and medical facilities as a pharmaceutical substitute for individuals having colorectal cancer.
Key players operating in the colorectal cancer treatment market include:
- Genentech, Inc (U.S.)
- Abbvie, Inc (U.S.)
- Novartis AG (Switzerland)
- Teva Pharmaceutical Industries Ltd (Israel)
- Pfizer Inc (U.S.)
- Hikma Pharmaceuticals PLC (U.K.)
- Alkem Labs Ltd (India)
- Accord Healthcare (U.K.)
- Zydus Group (India)
- Amneal Pharmaceutical Inc.(U.K.)
- Lilly (U.S.)
- Sanofi (France)
- Bausch Health Companies Inc. (Canada)
- Almirall, S.A (Spain)
- Fresenius Kabi USA (U.S.)
- Sagent Pharmaceuticals, Inc. (U.S.)
- Hill Dermaceuticals, Inc.(U.S.)
- Bristol-Myers Squibb Company (U.S.)
- Amgen Inc. (U.S.)
To Gain More Insights into the Market Analysis, Browse the Summary of the Research Report@ https://www.databridgemarketresearch.com/reports/global-colorectal-cancer-treatment-market?Shri
Colorectal Cancer Treatment Market Scope
Treatment
- Chemotherapy
- Targeted Therapy
- Radiation Therapy
- Surgery
- Immunotherapy
- Embolization
- Others
Route of Administration
- Oral
- Parenteral
- Others
End User
- Hospitals
- Homecare
- Specialty Clinics
- Others
Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on the product portfolios of the top players in the this research report
- Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and product launches in the market
- Competitive Assessment: In-depth assessment of the market strategies, and geographic and business segments of the leading players in the market
- Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies
Top Key Topics Covered:
- Strategic Imperatives
- Factors Creating Pressure on Growth
- The Strategic Imperative
- Growth Opportunities Fuel the Growth Pipeline Engine
- Research Methodology
- Scope and Segmentation
- Research Context and Scope of Analysis
- Segmentation
- Other Techniques for This Research Report Management
- Growth Opportunity Analysis
- Growth Drivers
- Growth Restraints
- Introduction
- The Impact of the COVID-19 Pandemic and Post
- Future Growth
- Innovation Ecosystem
Continued…
Browse Detailed Summary of Research Report with TOC: https://www.databridgemarketresearch.com/toc/?dbmr=global-colorectal-cancer-treatment-market&Shri
Some of the Most Important Questions Scrutinized in the Business Intelligence Report:
- What are the key growth parameters for this global market during the forecast period?
- Which key players are expected to hold the largest market share over the forecast period?
- Who are the leading vendors and manufacturers in this market?
- What are the key strategies adopted by leading players in the market for business development and geographical expansion?
- Which end-use industries can trigger high demand in the market over the forecast period?
- What are the key segments in this market?
- Which regional player will have anticipated leading the global market in terms of size?
- What is the impact of the novel coronavirus pandemic?
- Which obstacles must new players overcome in order to occupy a major position?
Top DBMR Healthcare Reports:
https://www.databridgemarketresearch.com/reports/global-cardasil-treatment-market?Shri
https://www.databridgemarketresearch.com/reports/global-aestheticcosmetic-lasers-market?Shri
https://www.databridgemarketresearch.com/reports/global-yeast-infection-market?Shri
About Data Bridge Market Research:
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.
Contact Us:-
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Editor Details
-
Company:
- The Wire Times
